Telix jumps on trial launch approval from T.G.A.
MELBOURNE: Melbourne biotech Telix Pharmaceuticals started Monday’s session up 5.3 per cent to ... read more
Adherium takes aim at rival over takeover offer
MELBOURNE: Respiratory health startup Adherium has urged its shareholders to reject an off-market ... read more